Cargando…
Caught you: threats to confidentiality due to the public release of large-scale genetic data sets
BACKGROUND: Large-scale genetic data sets are frequently shared with other research groups and even released on the Internet to allow for secondary analysis. Study participants are usually not informed about such data sharing because data sets are assumed to be anonymous after stripping off personal...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022540/ https://www.ncbi.nlm.nih.gov/pubmed/21190545 http://dx.doi.org/10.1186/1472-6939-11-21 |
_version_ | 1782196512698138624 |
---|---|
author | Wjst, Matthias |
author_facet | Wjst, Matthias |
author_sort | Wjst, Matthias |
collection | PubMed |
description | BACKGROUND: Large-scale genetic data sets are frequently shared with other research groups and even released on the Internet to allow for secondary analysis. Study participants are usually not informed about such data sharing because data sets are assumed to be anonymous after stripping off personal identifiers. DISCUSSION: The assumption of anonymity of genetic data sets, however, is tenuous because genetic data are intrinsically self-identifying. Two types of re-identification are possible: the "Netflix" type and the "profiling" type. The "Netflix" type needs another small genetic data set, usually with less than 100 SNPs but including a personal identifier. This second data set might originate from another clinical examination, a study of leftover samples or forensic testing. When merged to the primary, unidentified set it will re-identify all samples of that individual. Even with no second data set at hand, a "profiling" strategy can be developed to extract as much information as possible from a sample collection. Starting with the identification of ethnic subgroups along with predictions of body characteristics and diseases, the asthma kids case as a real-life example is used to illustrate that approach. SUMMARY: Depending on the degree of supplemental information, there is a good chance that at least a few individuals can be identified from an anonymized data set. Any re-identification, however, may potentially harm study participants because it will release individual genetic disease risks to the public. |
format | Text |
id | pubmed-3022540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30225402011-01-19 Caught you: threats to confidentiality due to the public release of large-scale genetic data sets Wjst, Matthias BMC Med Ethics Debate BACKGROUND: Large-scale genetic data sets are frequently shared with other research groups and even released on the Internet to allow for secondary analysis. Study participants are usually not informed about such data sharing because data sets are assumed to be anonymous after stripping off personal identifiers. DISCUSSION: The assumption of anonymity of genetic data sets, however, is tenuous because genetic data are intrinsically self-identifying. Two types of re-identification are possible: the "Netflix" type and the "profiling" type. The "Netflix" type needs another small genetic data set, usually with less than 100 SNPs but including a personal identifier. This second data set might originate from another clinical examination, a study of leftover samples or forensic testing. When merged to the primary, unidentified set it will re-identify all samples of that individual. Even with no second data set at hand, a "profiling" strategy can be developed to extract as much information as possible from a sample collection. Starting with the identification of ethnic subgroups along with predictions of body characteristics and diseases, the asthma kids case as a real-life example is used to illustrate that approach. SUMMARY: Depending on the degree of supplemental information, there is a good chance that at least a few individuals can be identified from an anonymized data set. Any re-identification, however, may potentially harm study participants because it will release individual genetic disease risks to the public. BioMed Central 2010-12-29 /pmc/articles/PMC3022540/ /pubmed/21190545 http://dx.doi.org/10.1186/1472-6939-11-21 Text en Copyright ©2010 Wjst; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Debate Wjst, Matthias Caught you: threats to confidentiality due to the public release of large-scale genetic data sets |
title | Caught you: threats to confidentiality due to the public release of large-scale genetic data sets |
title_full | Caught you: threats to confidentiality due to the public release of large-scale genetic data sets |
title_fullStr | Caught you: threats to confidentiality due to the public release of large-scale genetic data sets |
title_full_unstemmed | Caught you: threats to confidentiality due to the public release of large-scale genetic data sets |
title_short | Caught you: threats to confidentiality due to the public release of large-scale genetic data sets |
title_sort | caught you: threats to confidentiality due to the public release of large-scale genetic data sets |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022540/ https://www.ncbi.nlm.nih.gov/pubmed/21190545 http://dx.doi.org/10.1186/1472-6939-11-21 |
work_keys_str_mv | AT wjstmatthias caughtyouthreatstoconfidentialityduetothepublicreleaseoflargescalegeneticdatasets |